Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00054522
What this trial is testing

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT01950351
What this trial is testing

Hypofractionated Proton Beam Therapy for Localized Prostate Cancer

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
M.D. Anderson Cancer Center 241
Not applicableEnded earlyNCT00499174
What this trial is testing

Observation or Radical Treatment in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 180
Testing effectiveness (Phase 2)Study completedNCT00446836
What this trial is testing

Efficacy and Safety Study of Xyotax to Treat Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 29
Not applicableWithdrawnNCT07237399
What this trial is testing

Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)

Who this might be right for
Oligometastatic Prostate Cancer (OMPC)Prostate Cancer (Adenocarcinoma)Ablation Techniques
University Hospital, Ghent
Testing effectiveness (Phase 2)Study completedNCT00017563
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 57
Testing effectiveness (Phase 2)Ended earlyNCT02215161
What this trial is testing

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMetastatic Prostate Carcinoma in the Soft Tissue+3 more
University of California, San Francisco 14
Testing effectiveness (Phase 2)Study completedNCT00080899
What this trial is testing

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT00054106
What this trial is testing

Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 25
Large-scale testing (Phase 3)Study completedNCT00063882
What this trial is testing

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 588
Testing effectiveness (Phase 2)Study completedNCT00814788
What this trial is testing

Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, Davis 24
Testing effectiveness (Phase 2)Ended earlyNCT00073970
What this trial is testing

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT05253053
What this trial is testing

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more
TransThera Sciences (Nanjing), Inc. 84
Testing effectiveness (Phase 2)Study completedNCT00015977
What this trial is testing

Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Chicago 13
Testing effectiveness (Phase 2)Looking for participantsNCT07179783
What this trial is testing

Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Castration-ResistantProstate Adenocarcinoma With Neuroendocrine Differentiation
Tianjin Medical University Second Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00574769
What this trial is testing

Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of Southern California 27
Testing effectiveness (Phase 2)Study completedNCT00028769
What this trial is testing

S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 41
Early research (Phase 1)Study completedNCT00804245
What this trial is testing

C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 18
Testing effectiveness (Phase 2)Study completedNCT00151060
What this trial is testing

Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 28
Testing effectiveness (Phase 2)WithdrawnNCT06528210
What this trial is testing

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

Who this might be right for
High Risk Prostate CarcinomaLocalized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8+2 more
OHSU Knight Cancer Institute
Next Page